Literature DB >> 8004445

Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients.

P Gómez-Ramos1, C Bouras, M A Morán.   

Abstract

Butyrylcholinesterase histochemical techniques were applied to vibratome sections of several cortical areas from the brains of non-demented aged and of Alzheimer's disease patients. At the light microscope level, all the senile plaque types and all the structures with neurofibrillary degeneration showed butyrylcholinesterase reaction product, whereas nearby neuronal perikarya and axons on the same slides remained unstained. Areas containing stained elements were selected, re-sectioned, and finally observed under the electron microscope. Focusing on the sites of neurofibrillary degeneration, butyrylcholinesterase reaction product was found in both intra- and extracellular neurofibrillary tangles, in neurites associated with plaques, and in neuropil threads that were either axons or dendrites. This reaction product was exclusively located over filament bundles, and sometimes covered them so completely that they could not be identified. When the filaments were only partially covered, it was possible to identify them as either paired helical filaments or straight filaments. Occasionally, neurofibrillary tangles, neuropil threads and plaque-associated neurites, all of them containing either paired helical filaments or straight filaments, were found to be completely free of butyrylcholinesterase reaction product. The origin and possible role of butyrylcholinesterase, which is ultrastructurally localized over elements presenting neurofibrillary degeneration, is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004445     DOI: 10.1016/0006-8993(94)91852-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.

Authors:  R Schliebs; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

3.  Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin.

Authors:  S Darvesh; R Kumar; S Roberts; R Walsh; E Martin
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

4.  BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.

Authors:  Alessandra Bizzarro; V Guglielmi; R Lomastro; A Valenza; A Lauria; C Marra; M C Silveri; F D Tiziano; C Brahe; C Masullo
Journal:  J Neural Transm (Vienna)       Date:  2010-03       Impact factor: 3.575

Review 5.  Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Aleksandra Szydłowska; Agata Skupień; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

6.  Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients.

Authors:  Natsalil Pongthanaracht; Somchai Yanarojana; Darawan Pinthong; Supeenun Unchern; Amnuay Thithapandha; Prasert Assantachai; Porntip Supavilai
Journal:  Clin Interv Aging       Date:  2017-05-26       Impact factor: 4.458

7.  Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.

Authors:  Ian R Macdonald; Selena P Maxwell; George A Reid; Meghan K Cash; Drew R DeBay; Sultan Darvesh
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.

Authors:  Jacek Jasiecki; Anna Limon-Sztencel; Monika Żuk; Magdalena Chmara; Dominik Cysewski; Janusz Limon; Bartosz Wasąg
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

9.  Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could BCHE Genotyping Be Helpful in Alzheimer's Therapy?

Authors:  Jacek Jasiecki; Bartosz Wasąg
Journal:  Biomolecules       Date:  2019-10-09

Review 10.  The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer's Disease Pathogenesis.

Authors:  Jacek Jasiecki; Monika Targońska; Bartosz Wasąg
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.